Literature DB >> 15528341

Induction of bystander suppression by feeding antigen occurs despite normal clonal expansion of the bystander T cell population.

Owain R Millington1, Allan McI Mowat, Paul Garside.   

Abstract

The induction of bystander suppression, whereby the response against one Ag is suppressed when it is presented in the context of an Ag to which tolerance is already established, would be an important property of oral tolerance, because it would allow treatment of autoimmune and hypersensitivity responses where the initiating Ag is not known. Although bystander suppression has been described in oral tolerance, it is not known how its effects are mediated at the level of the bystander T cells. In addition, previous studies have not compared regimes in which Ag is fed in a tolerogenic or immunogenic manner, meaning that the possible effects of Ag competition have not been excluded. In this study we have used two populations of Ag-specific TCR transgenic CD4(+) T cells to examine the cellular basis of bystander suppression associated with oral tolerance in mice in vitro and in vivo. Our results show that bystander responses can be inhibited by feeding Ag and that these effects are more pronounced in mice fed protein in tolerogenic form than after feeding Ag with mucosal adjuvant. However, the expansion of the bystander-specific CD4(+) T cells is not influenced by the presence of oral tolerance. Thus, bystander suppression does not reflect clonal deletion or reduced clonal expansion of the bystander T cells, but may act by altering the functional differentiation of bystander T cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15528341     DOI: 10.4049/jimmunol.173.10.6059

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Differential regulation of Toll-like receptor signalling in spleen and Peyer's patch dendritic cells.

Authors:  Julie M Davies; John MacSharry; Fergus Shanahan
Journal:  Immunology       Date:  2010-11       Impact factor: 7.397

2.  Characterization of CD4+ T-cell-dendritic cell interactions during secondary antigen exposure in tolerance and priming.

Authors:  Catherine M Rush; Owain R Millington; Sharon Hutchison; Karen Bryson; James M Brewer; Paul Garside
Journal:  Immunology       Date:  2009-12       Impact factor: 7.397

3.  In situ characterization of CD4+ T cell behavior in mucosal and systemic lymphoid tissues during the induction of oral priming and tolerance.

Authors:  Bernd H Zinselmeyer; John Dempster; Alison M Gurney; David Wokosin; Mark Miller; Hsiang Ho; Owain R Millington; Karen M Smith; Catherine M Rush; Ian Parker; Michael Cahalan; James M Brewer; Paul Garside
Journal:  J Exp Med       Date:  2005-05-31       Impact factor: 14.307

4.  Autoantigens plus interleukin-10 suppress diabetes autoimmunity.

Authors:  Béla Dénes; István Fodor; William H R Langridge
Journal:  Diabetes Technol Ther       Date:  2010-08       Impact factor: 6.118

Review 5.  Role of orally induced regulatory T cells in immunotherapy and tolerance.

Authors:  Thais B Bertolini; Moanaro Biswas; Cox Terhorst; Henry Daniell; Roland W Herzog; Annie R Piñeros
Journal:  Cell Immunol       Date:  2020-11-14       Impact factor: 4.868

6.  Persistent suppression of type 1 diabetes by a multicomponent vaccine containing a cholera toxin B subunit-autoantigen fusion protein and complete Freund's adjuvant.

Authors:  Béla Dénes; István Fodor; William H R Langridge
Journal:  Clin Dev Immunol       Date:  2013-11-11

7.  Oral Tolerance Induction in Experimental Autoimmune Encephalomyelitis with Candida utilis Expressing the Immunogenic MOG35-55 Peptide.

Authors:  Christoph Buerth; Anne K Mausberg; Maximilian K Heininger; Hans-Peter Hartung; Bernd C Kieseier; Joachim F Ernst
Journal:  PLoS One       Date:  2016-05-09       Impact factor: 3.240

8.  Adoptive transfer of dendritic cells expressing CD11c reduces the immunological response associated with experimental colitis in BALB/c mice.

Authors:  Lisiery N Paiatto; Fernanda G D Silva; Áureo T Yamada; Wirla M S C Tamashiro; Patricia U Simioni
Journal:  PLoS One       Date:  2018-05-08       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.